Nanomaterial standards for efficacy and toxicity assessment.
about
Applications of nanotechnology in dermatologyA Raman-based endoscopic strategy for multiplexed molecular imaging.A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticleEmerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systemsTargeted nanotechnology for cancer imaging.Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilitiesUltrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic CancerPre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategyNanoinformatics: a new area of research in nanomedicineEngineered nanomaterials in food: implications for food safety and consumer healthNanoparticles for cancer imaging: The good, the bad, and the promiseProvenance information as a tool for addressing engineered nanoparticle reproducibility challengesDawn of advanced molecular medicine: nanotechnological advancements in cancer imaging and therapy.Imaging and drug delivery using theranostic nanoparticlesModern micro and nanoparticle-based imaging techniquesPreclinical evaluation of Raman nanoparticle biodistribution for their potential use in clinical endoscopy imaging.Perspective highlights on biodegradable polymeric nanosystems for targeted therapy of solid tumorsShaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticlesCancer targeted therapeutics: From molecules to drug delivery vehicles.Therapeutic effects of long-circulating miR-135a-containing cationic immunoliposomes against gallbladder carcinoma.Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer.Nanoparticles as magnetic resonance imaging contrast agents for vascular and cardiac diseases.Recommendations for Benchmarking Preclinical Studies of NanomedicinesImaging metastasis using an integrin-targeting chain-shaped nanoparticle.Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory.Biopolymer-based nanoparticles for drug/gene delivery and tissue engineering.Targeted polymeric therapeutic nanoparticles: design, development and clinical translationTranscriptional responses of human aortic endothelial cells to nanoconstructs used in biomedical applicationsSurface characterization of nanomaterials and nanoparticles: Important needs and challenging opportunities.Treatment of cancer micrometastasis using a multicomponent chain-like nanoparticle.Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice.Intracellularly Swollen Polypeptide Nanogel Assists Hepatoma Chemotherapy.Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery.Drug delivery from structured porous inorganic materials.Tailoring nanocarriers for intracellular protein delivery.In vivo biodistribution of nanoparticles.Treating metastatic cancer with nanotechnology.Advancement in multifunctional nanoparticles for the effective treatment of cancer.Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking.Nano-graphene oxide: a potential multifunctional platform for cancer therapy.
P2860
Q24170384-2DEE3BBC-54CC-45FB-842E-3EEE6B599E0EQ24609293-AA1CEF8A-8533-42E6-8BA4-95FCB8406011Q24615790-C012C711-3E2F-4E53-B5B8-B9415C842850Q26996159-298921F1-1B4B-4231-B937-C68BCDE6C716Q27010317-36ACE17E-E4D8-45B9-9E50-05C50DE2937AQ27011598-845BB9E5-14B8-4A51-9939-61D09C529D8FQ27300789-5A2B7D1A-DCD4-4916-85A7-756072F40CD4Q28081577-A16CA90A-FE3D-4B4D-BABC-BDEFB05CFBFAQ28387114-61DD3683-4D14-4C12-A840-1DD2C82B74C8Q28389204-649D6A30-26D7-4DD7-9E34-F52D058B137DQ28651643-C15AE53A-CD25-46D2-B0CC-9C0B8CDBBB5DQ29048614-4FC0DB74-0109-4A03-AFC7-8DDF8CC9EEA0Q30421668-CCE1F5AF-EE61-4F9D-BFB0-AD3E8BF07771Q30449480-8CE4160D-A472-42D1-BC25-474A8C5343A9Q30459277-08AEDDDC-7056-425C-8261-496FA20A0301Q30586800-81E759A6-694F-458B-9845-04AA828673BAQ33712145-4B50B110-13F8-4631-B84A-3048AF00E5E2Q33755231-9A4AD449-7AD8-4C5E-A96A-33D5CAC8FCF2Q33887986-6E735CEA-291C-4917-8D37-744D89BC3F78Q33921112-1B9EE7FC-E7C8-4BE2-99B7-8EC11270C455Q34537580-8ED5BA1B-5448-4D9B-B005-641F8BFA9949Q35667247-7B462120-0849-43CB-B0B0-3F0F00181A03Q36118071-3CE1011E-826F-4AF5-90E0-0BE2BF321941Q36366404-68621AB0-7BDE-4F63-B4E9-62FE06798C12Q36403660-98F5067C-937B-400D-9851-DFFFF68532B2Q36590092-85C2E552-8CF2-4BEA-8397-6952EF5C8BD9Q36934007-5D1B6EBE-3857-4D9B-9373-1EA35765C86BQ37173808-2EB12CFE-17D3-4F76-A108-AA4A65190443Q37406394-E1AC30FE-07F8-4D0F-8899-AFB0CBEC7F9AQ37415867-E3236153-22F0-4F8D-B176-0C243E67BA6CQ37467770-0E218742-34D8-49B7-A5F5-C80CFFD67D6AQ37668568-7017C38E-D6A8-4B52-8181-33101CD835D0Q37775972-E789897F-FD66-4248-9EB6-FD4A98E414FFQ37849730-BE637514-115F-4A1D-8EF4-EBCCE5757361Q37874945-88FF573A-EF4E-4AA9-ADCD-834D46F18585Q37906630-416AC8A3-5471-445F-B4D2-24E6C29A7051Q37970910-EF328F62-379D-4275-B40A-9B254CDA8C3DQ37991742-29B2281D-0673-4C64-83D7-B0098974EFB3Q38047267-0F347E87-3415-4793-AE11-66095B747DCBQ38092811-D20220C0-5589-4B28-B74C-09C5F49A745B
P2860
Nanomaterial standards for efficacy and toxicity assessment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nanomaterial standards for efficacy and toxicity assessment.
@en
Nanomaterial standards for efficacy and toxicity assessment.
@nl
type
label
Nanomaterial standards for efficacy and toxicity assessment.
@en
Nanomaterial standards for efficacy and toxicity assessment.
@nl
prefLabel
Nanomaterial standards for efficacy and toxicity assessment.
@en
Nanomaterial standards for efficacy and toxicity assessment.
@nl
P2093
P2860
P356
P1476
Nanomaterial standards for efficacy and toxicity assessment.
@en
P2093
Jennifer B Hall
Pavan P Adiseshaiah
Scott E McNeil
P2860
P304
P356
10.1002/WNAN.66
P577
2010-01-01T00:00:00Z